Skip to content
Business Company News, Oil Mining Resources

Locksley Resources Identifies Rare Earths Targets at Mojave Project from High-Resolution Airborne Geophysical Survey

Jane Morgan Management 2 mins read

10 December 2025 – Perth, Australia, | Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF; FSE: X5L) has today announced the completion and interpretation of a new high-resolution helicopter-borne magnetic and radiometric survey across its Mojave Project in California, USA, identifying new rare earth element target areas adjacent to the Mountain Pass district.

Kerrie Matthews, Managing Director & CEO, commented: "The results from this high-resolution geophysical survey are a game-changer for our targeting at Mojave. Moving from broad legacy geophysical data to this level of detail is like turning on the lights in a dark room. We can now see clearly defined structural corridors and Thorium anomalies that look geologically similar to the systems, known in the district. The identification of a potential parallel system near El Campo is particularly exciting and will be a priority for our field teams."

The survey results have defined a new Thorium anomaly within the Mojave Project’s North Block claims, including a notable weathering feature associated with regional drainage, and multiple additional discrete anomalies now being assessed and ranked. A second new Thorium anomaly was also identified, trending parallel to, and approximately 700 metres east of, the high-grade El Campo Prospect, providing potential for parallel mineralisation.

Thorium is considered an important pathfinder for rare earth element mineralisation in the district. The Company also highlighted that the nearby Mountain Pass Rare Earth Mine is characterised by a strong Thorium signature, supporting the relevance of radiometric anomalies as priority follow-up targets. The Company cautioned that radiometric sensors detect gamma rays from the upper ~20–30 centimetres of the surface, meaning anomalies represent surface expressions that require field validation rather than direct detection of mineralisation at depth.

Field teams are now deployed to ground-truth the newly identified anomalies, with mapping and rock chip sampling underway to verify and prioritise targets. Structural interpretation is ongoing, and the Company said this work is intended to support future drill target definition.

For further information, please contact:

Kerrie Matthews
Chief Executive Officer
[email protected]

Jane Morgan
Investor & Media Relations
[email protected]


About us:

ABOUT LOCKSLEY RESOURCES LIMITED

Locksley Resources Limited is focused on critical minerals in the United States of America. The Company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at re-establishing domestic supply chains for critical materials, underpinned by strategic downstream technology partnerships with leading U.S. research institutions and industry partners. This integrated approach combines resource development with innovative processing and separation technologies, positioning Locksley to play a key role in advancing U.S. critical minerals independence.


Contact details:

Jane Morgan
Jane Morgan Management
Investory & Media Relations
[email protected]

Media

More from this category

  • Biotechnology, Business Company News
  • 10/12/2025
  • 10:17
Jane Morgan Management

TGA Provides Regulatory Clearance for LTR Pharma’s SPONTANĀ® Phase II Clinical Study

10 December 2025 – Brisbane, Australia |LTR Pharma Limited (ASX:LTP) has today announced that it has received regulatory clearance from Australia’s Therapeutic Goods Administration (TGA) to commence its clinical trial activities for a Phase II clinical study for its nasal erectile dysfunction treatment SPONTAN®. This follows confirmation and acceptance of the Company’s Clinical Trial Notification (CTN). This regulatory clearance completes all requirements for study initiation in Australia and follows recent Human Research Ethics Committee (HREC) approval granted by Bellberry announced previously. LTR Pharma Executive Chairman, Lee Rodne, said: "The TGA’s regulatory clearance of our CTN represents an important milestone that…

  • Contains:
  • Business Company News, Finance Investment
  • 10/12/2025
  • 10:03
Hnry

Fintech Hnry Raises $30m to Accelerate Push into Australia and the UK

Key Facts: Hnry raises $30 million in fresh capital. Hnry will use the funds to grow its Australian and UK markets. Movac’s Growth Fund…

  • Contains:
  • Business Company News, General News
  • 10/12/2025
  • 08:00
Jirsch Sutherland

Festive spending warning: Aussies urged to act now

Key Facts: Australians risk significant post-Christmas debt with household spending up 5% year-on-year and savings ratios down to 4-5% Household costs have increased across…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.